Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 9, 2025 • 6:00 AM ET

Date/Time Source News Release
05/12/2025 07:30 AM EDT GlobeNewswire ProMIS Neurosciences Announces First Quarter 2025 Financial Results
03/31/2025 07:00 AM EDT GlobeNewswire ProMIS Neurosciences Announces Full Year 2024 Financial Results and Recent Highlights
03/24/2025 07:00 AM EDT GlobeNewswire ProMIS Neurosciences Showcases Preclinical Data on Platform-Derived Antibody and Vaccines for Neurodegenerative Diseases at Alzheimer's Disease/Parkinson's Disease 2025 International Conference
03/13/2025 07:00 AM EDT GlobeNewswire ProMIS Neurosciences Showcases Preclinical Data on Platform Derived Vaccines for Neurodegenerative Diseases at the American Academy of Neurology 2025 Annual Meeting
03/11/2025 07:30 AM EDT GlobeNewswire ProMIS Neurosciences to Participate in the 37th Annual Roth Conference
02/25/2025 07:00 AM EST GlobeNewswire ProMIS Neurosciences Doses First Patients in Phase 1b PRECISE-AD Trial of PMN310 for Alzheimer's Disease
01/29/2025 07:30 AM EST GlobeNewswire ProMIS Neurosciences to Participate in Guggenheim Securities SMID Cap Biotech Conference
01/13/2025 10:30 AM EST GlobeNewswire ProMIS Neurosciences Issues Letter to Shareholders
01/10/2025 07:00 AM EST GlobeNewswire ProMIS Neurosciences Initiates Phase 1b Clinical Trial (PRECISE-AD) in Alzheimer's Disease
11/26/2024 07:00 AM EST GlobeNewswire ProMIS Neurosciences to Participate in 7th Annual Evercore HealthCONx Conference
Page

Additional News

As of June 9, 2025 • 6:00 AM ET

Date/Time Source News Release
05/13/2025 05:31 AM EDT US Earnings Reports Expected earnings - ProMIS Neurosciences Inc.
05/12/2025 01:35 PM EDT SeekingAlpha ProMIS Neurosciences GAAP EPS of -$0.21
04/01/2025 05:30 AM EDT US Earnings Reports Expected earnings - ProMIS Neurosciences Inc.
03/31/2025 01:24 PM EDT SeekingAlpha ProMIS Neurosciences GAAP EPS of $0.11
02/19/2025 05:53 PM EST SeekingAlpha ProMIS Neurosciences dismisses COO position
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - ProMIS Neurosciences Inc.
11/14/2024 03:12 PM EST SeekingAlpha ProMIS Neurosciences GAAP EPS of $0.31 beats by $0.38
08/29/2024 04:49 PM EDT SeekingAlpha ProMIS Neurosciences files to sell 56.51M common shares for holders
08/09/2024 10:10 AM EDT SeekingAlpha ProMIS Neurosciences GAAP EPS of -$0.13
05/15/2024 06:45 AM EDT SeekingAlpha ProMIS Neurosciences GAAP EPS of -$0.19
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.